Real-time updates from leading research institutions and scientific journals
Researchers at Stanford University have developed a new peptide that demonstrates significant potential in reducing amyloid plaques associated with Alzheimer's disease. The peptide, designated APX-001, showed a 45% reduction in plaque formation in preclinical trials.
The FDA has approved Phase II clinical trials for BPC-157 in treating inflammatory bowel disease (IBD). The study will enroll 200 patients across 15 medical centers to evaluate efficacy and safety in Crohn's disease and ulcerative colitis.
A new study published in the Journal of Dermatological Science demonstrates that GHK-Cu copper peptides accelerate wound healing by 60% compared to standard treatments. The research highlights enhanced collagen synthesis and angiogenesis as key mechanisms.
Artificial intelligence has been used to design peptides with dramatically improved stability and bioavailability. The AI-optimized peptides maintain therapeutic activity for 10 times longer than conventional designs, potentially enabling oral delivery.
The FDA has approved a next-generation GLP-1 receptor agonist peptide for chronic weight management. The once-weekly injection demonstrated an average weight loss of 15% in clinical trials with improved cardiovascular outcomes.
Scientists have isolated novel peptides from deep-sea organisms that demonstrate powerful anti-cancer activity. The marine-derived peptides selectively target cancer cells while sparing healthy tissue, opening new avenues for cancer therapy.
Researchers have developed a revolutionary nanoparticle system that protects peptides from digestive enzymes, enabling effective oral delivery. This technology could eliminate the need for injections for many peptide therapeutics.
A controlled study of TB-500 in professional athletes demonstrates significantly faster recovery from muscle injuries. The peptide reduced recovery time by an average of 40% compared to standard rehabilitation protocols.
Get daily updates on peptide research, clinical trials, and scientific breakthroughs delivered to your inbox.
Return to Homepage